Paul Ashton

Company: Inflammasome Therapeutics

Job title: President and CEO

Seminars:

Showcasing the Latest Clinical Updates from Inflammasome Therapeutics 9:00 am

Outlining the mechanism of action Delving into the preclinical data Defining the next steps for the clinical trial Read more

day: Conference Day 1